Sham Innovation Santé
Corporate investor
Active
Lyon, France
22
21M
13
0.23
0.41
2
- Areas of investment
Summary
Among the most popular portfolio startups of the fund, we may highlight CarThera, Horama, Antabio. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Health Care, Genetics.
The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Sham Innovation Santu00e9, startups are often financed by Octalfa, Bpifrance, Wellcome Trust. The meaningful sponsors for the fund in investment in the same round are Octalfa, Pontifax, Omnes Capital. In the next rounds fund is usually obtained by Octalfa, V-Bio Ventures, Sofimac Partners.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 22
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.23
- Follow on index
- 0.41
- Investments by industry
- Medical (12)
- Health Care (12)
- Biotechnology (11)
- Pharmaceutical (6)
- Medical Device (6) Show 10 more
- Investments by region
-
- France (22)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 23M
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
- Avg. multiplicator
- 2.41
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Horama | 08 Nov 2017 | Biotechnology, Genetics, Life Science, Neuroscience | Early Stage Venture | 22M | Ile-de-France, Paris, France |
| Horama | 21 Jul 2021 | Biotechnology, Genetics, Life Science, Neuroscience | Early Stage Venture | 38M | Ile-de-France, Paris, France |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.